Won-Jea Cho Selected Research

Parkinson Disease (Parkinson's Disease)

1/2016

Insights into the Structural Features Essential for JAK2 Inhibition and Selectivity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Won-Jea Cho Research Topics

Disease

20	Neoplasms (Cancer) 01/2018 - 09/2002
6	Infections 10/2020 - 05/2012
5	Prostatic Neoplasms (Prostate Cancer) 12/2016 - 08/2012
3	Alzheimer Disease (Alzheimer's Disease) 08/2022 - 01/2016
3	Virus Diseases (Viral Diseases) 01/2022 - 10/2020
3	Inflammation (Inflammations) 11/2019 - 01/2016
2	Melanoma (Melanoma, Malignant) 01/2020 - 07/2015
2	Hyperpigmentation 01/2020 - 07/2015
2	Acute Liver Failure (Fulminant Hepatic Failure) 11/2017 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 06/2012 - 02/2008
1	Chronic Hepatitis C 10/2020
1	Non-alcoholic Fatty Liver Disease 11/2019
1	Sudden Death 11/2017
1	Sepsis (Septicemia) 01/2017
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2017
1	Septic Shock (Toxic Shock Syndrome) 01/2017
1	Shock 01/2017
1	Hematologic Neoplasms (Hematological Malignancy) 11/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2016
1	Essential Thrombocythemia 01/2016
1	Parkinson Disease (Parkinson's Disease) 01/2016
1	Atherosclerosis 01/2016
1	Primary Myelofibrosis (Myelosclerosis) 01/2016
1	Polycythemia Vera 01/2016
1	Obesity 01/2016
1	Rheumatoid Arthritis 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Adenocarcinoma 07/2014
1	Skin Diseases (Skin Disease) 08/2013
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2013
1	Neonatal Jaundice 01/2013
1	Experimental Melanoma 11/2011

Drug/Important Bio-Agent (IBA)

7	Type I DNA Topoisomerases (Topoisomerase I)IBA 06/2012 - 01/2010
5	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 01/2010
3	Cyclophilin AIBA 01/2022 - 12/2015
3	Melanins (Melanin)IBA 01/2020 - 11/2011
3	Biological ProductsIBA 01/2018 - 03/2015
3	Phosphotransferases (Kinase)IBA 01/2017 - 11/2010
3	Androgen Receptors (Androgen Receptor)IBA 12/2016 - 08/2012
2	Antiviral Agents (Antivirals)IBA 07/2021 - 10/2020
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2017
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2019 - 02/2008
2	trioctyl phosphine oxide (TOPO)IBA 01/2018 - 01/2011
2	AndrogensIBA 12/2016 - 08/2012
2	Pharmaceutical PreparationsIBA 01/2016 - 09/2010
2	PyridinesIBA 02/2012 - 05/2010
2	pyridineIBA 03/2010 - 01/2010
1	tau Proteins (tau Protein)IBA 08/2022
1	hexosaminidase CIBA 08/2022
1	VaccinesIBA 07/2021
1	Peptide Hydrolases (Proteases)FDA Link 10/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Stem Cell FactorIBA 01/2020
1	7,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acidIBA 11/2019
1	Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA 11/2019
1	PoisonsIBA 01/2018
1	Myeloid Differentiation Factor 88IBA 11/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2017
1	Toll-Like Receptor 4IBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	Toll-Like Receptor AgonistsIBA 01/2017
1	GalactosamineIBA 01/2017
1	caffeic acidIBA 01/2017
1	Niacinamide (Nicotinamide)FDA LinkGeneric 12/2016
1	Alanine (L-Alanine)FDA Link 12/2016
1	Prostate-Specific Antigen (Semenogelase)IBA 12/2016
1	Poly (ADP-Ribose) Polymerase-1IBA 12/2016
1	Selenoprotein PIBA 12/2016
1	Proline (L-Proline)FDA Link 12/2016
1	Caspase 3 (Caspase-3)IBA 12/2016
1	Tyrosine Kinase InhibitorsIBA 11/2016
1	Therapeutic UsesIBA 01/2016
1	EnzymesIBA 01/2016
1	BerberineIBA 01/2016
1	Melanocyte-Stimulating Hormones (MSH)IBA 07/2015
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 07/2015
1	diphenylmethylene hydrazinecarbothioamideIBA 07/2015
1	CamptothecinIBA 07/2014
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 07/2014
1	Etoposide (VP 16)FDA LinkGeneric 07/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2014
1	daidzeinIBA 08/2013
1	LigandsIBA 08/2013
1	RetinoidsIBA 08/2013
1	TubulinIBA 08/2013
1	Androgen Receptor AntagonistsIBA 04/2013
1	src-Family KinasesIBA 04/2013
1	Small Interfering RNA (siRNA)IBA 04/2013
1	scoparoneIBA 01/2013
1	AgarIBA 01/2013
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2013
1	6- (3,4- dihydro- 1H- isoquinolin- 2- yl)- N- (6- methylpyridin- 2- yl)nicotinamideIBA 08/2012
1	Glucose (Dextrose)FDA LinkGeneric 06/2012
1	LipidsIBA 05/2012
1	Nonesterified Fatty Acids (NEFA)IBA 05/2012
1	quinolineIBA 02/2012
1	Monophenol Monooxygenase (Tyrosinase)IBA 11/2011

Therapy/Procedure

5	Therapeutics 10/2020 - 02/2008
1	Punctures 01/2017
1	Ligation 01/2017